Toxicity risk assessment

Ahlborg UG, Hanberg A. 1992. Toxicokinetics of PCDDs and PCDFs of importance to the development of human risk assessment. Toxic Substances Journal 12 197-211. 

Key words Chemical risk assessment, Toxicity testing, Alternative to animal experimentation, Animal-free, In vitro test systems, Systems toxicology... 

Organization for HAZMAT Emergencies Part 1 Hazards Analysis Uses case studies to explain hazard identification, vulnerability analysis, risk assessment toxicity, flammability, and reactivity of chemicals prioritizing hazards and how vapor plumes are affected by weather and chemical composition. 

As already stressed, these techniques involve many analytical steps such as extraction, derivatization, separation and detection, which should be performed in such a way that decay of the unstable species does not occur. However, the control of the quality of measurements is often hampered by the lack of suitable reference materials for speciation analyses. Research is hence directed towards the development of new (if possible simple) analytical methods, the production of reference materials, and the monitoring of chemical species for various purposes (environmental risk assessment, toxicity studies, biogeochemical cycles of trace elements, etc.). 

C The Cornerstone of Risk Assessment Toxicity Testing in Animals... 

Hazard identification involves gathering and evaluating data on the types of health injury or disease that may be produced by a chemical and on the conditions of exposure under which injury or disease is produced. It may also involve characterization of the behavior of a chemical within the body and the interactions it undergoes with organs, cells, or even parts of cells. Hazard identification is not risk assessment. It is a scientific determination of whether observed toxic effects in one setting will occur in other settings. 

Formaldehyde Risk Assessment Update, Office of Toxic Substances, U.S. Environmental Protection Agency, Washington, D.C., June 11,1991. 

It is obvious from the provisional risk assessment values for microcystins, and, being of the same order of magnitude of mammalian toxicity, similar values may be calculated for the cyanobacterial neurotoxins, that sensitive detection methods are required to detect these low concentrations of toxins. Of the biological methods of detection discussed earlier, the mouse and invertebrate bioassays are not sensitive enough without concentration of water samples, in that they are only able to detect mg of microcystins per litre. Only the immunoassays (ng-/rg 1 and the protein phosphatase inhibition assays (ng O... 

The final article, by S. G. Bell and G. A. Codd of the University of Dundee Department of Biological Services, is concerned with detection, analysis, and risk assessment of cyanobacterial toxins. These can be responsible for animal, fish, and bird deaths and for ill-health in humans. The occurrence of toxic cyanobacterial blooms and scums on nutrient-rich waters is a world-wide phenomenon and cases are cited from Australia, the USA, and China, as well as throughout Europe. The causes, indentification and assessment of risk, and establishment of criteria for controlling risk are discussed. 

TRACE II Toxic Release Analysis of Chemical Emissions Safer Emergency Systems, Inc. Darlene Davis Dave Dillehay 756 Lakefield Road Westlake Villa, CA 91361 (818) 707-2777 Models toxic gas and flammable vapor cloud dispersion. Intended for risk assessment and planning purposes, rather than realtime emergencies. 

Toxicity, Risks, and Risk Assessment References 336 Bibliography 344... 

Most human or environmental healtli hazards can be evaluated by dissecting tlie analysis into four parts liazard identification, dose-response assessment or hazard assessment, exposure assessment, and risk characterization. For some perceived healtli liazards, tlie risk assessment might stop with tlie first step, liazard identification, if no adverse effect is identified or if an agency elects to take regulatory action witliout furtlier analysis. Regarding liazard identification, a hazard is defined as a toxic agent or a set of conditions that luis the potential to cause adverse effects to hmnan health or tlie environment. Healtli hazard identification involves an evaluation of various forms of information in order to identify the different liaz.ards. Dose-response or toxicity assessment is required in an overall assessment responses/cffects can vary widely since all chemicals and contaminants vary in their capacity to cause adverse effects. This step frequently requires that assumptions be made to relate... 

Chronic. Continuous exposure occurs over long periods of time, generally several mondis to years. Concentradons of inlialed (toxic) contaminants are usually reladvely low. This subject area falls in die general domain of healdi risk assessment (HRA) and it is diis subject tliat is addressed in die next five chapters. Thus, in contrast to the acute (short-term) exposures dial predominate in hazard risk assessments, cliroiiic (loiig-temi) exposures are the major concern in health risk assessments. 

Since 1970 tlie field of healtli risk assessment Itas received widespread attention witliin both tlie scientific and regulatoiy committees. It has also attracted tlie attention of the public. Properly conducted risk assessments have received fairly broad acceptance, in part because they put into perspective the terms to. ic, Itazard, and risk. Toxicity is an inlierent property of all substances. It states tliat all chemical and physical agents can produce adverse healtli effects at some dose or under specific exposure conditions. In contrast, exposure to a chemical tliat lias tlie capacity to produce a particular type of adverse effect, represents a health hazard. Risk, however, is tlie probability or likelihood tliat an adverse outcome will occur in a person or a group tliat is exposed to a particular concentration or dose of the hazardous agent. Tlierefore, risk can be generally a function of exposure and dose. Consequently, healtli risk assessment is defined as tlie process or procedure used to estimate tlie likelihood that... 

Much of the attention focused on e.xposure assessment has come recently. This is because many of the risk assessments done in tlie past used too many conseix ative assumptions, wliich caused an ovcrcstimation of the actual exposure. Without exposures there are no risks. To experience adverse effects, one must first come into contact with the toxic agent(s). Exposures to chemicals can be via inlialation of air (brcatliing), ingestion of water and food (eating and drinking), or absorption Uu ough the skin. These arc all pathways to the human body. 

If there are specific data germane to the assumption of dose-additivity (e g., if two compounds arc present at the same site and it is known that the combination is five times more toxic than the sum of the toxicitics for the two compounds), then tire development of the hazard index should be modified accordingly. The reader can refer to the EPA (1986b) mi.xiure guidelines for discussion of a hazjird index equation that incorporates quantitative interaction data. If data on chemical interactions are available, but arc not adequate to support a quantitative assessment, note the information in the assumptions being documented for the risk assessment. 

Thus, tlie focus of tliis subsection is on qualitative/semiquantitative approaches tliat can yield useful information to decision-makers for a limited resource investment. There are several categories of uncertainties associated with site risk assessments. One is tlie initial selection of substances used to characterize exposures and risk on tlie basis of the sampling data and available toxicity information. Oilier sources of uncertainty are inlierent in tlie toxicity values for each substance used to characterize risk. Additional micertainties are inlierent in tlie exposure assessment for individual substances and individual exposures. These uncertainties are usually driven by uncertainty in tlie chemical monitoring data and tlie models used to estimate exposure concentrations in tlie absence of monitoring data, but can also be driven by population intake parameters. As described earlier, additional micertainties are incorporated in tlie risk assessment when exposures to several substances across multiple patliways are suimned. 

Note The souree for the above risk values is Table III-7, Preliminary Caneer Poteuey Values for Uie Air Toxies Hot Spots aet, found in California Air Pollution Control Offieers Assoeiation, Air Toxics Hot Spots Program, Revised 1192 Risk Assessment Guidelines," page III-28, published Oetober 1993. 

Tlie reader should also note that tlie risk to people can be defined in terms of injury or fatality. The use of injuries as a basis of risk evaluation may be less disturbing tlian tlie use of fatalities. However, tliis introduces problems associated with degree of injury and comparability between different types of injuries. Further complications am arise in a risk assessment when dealing witli multiple hazards. For example, how are second-degree bums, fragment injuries, and injuries due to toxic gas e.xposure combined Even where only one type of effect (e.g., tlueshold to.xic exposure) is being evaluated, different durations of e.xposure can markedly affect tlie severity of injury. 

The reader should note tliat since many risk assessments have been conducted on the basis of fatal effects, there are also uncertainties on precisely what constitutes a fatal dose of thennal radiation, blast effect, or a toxic chemical. Where it is desired to estimate injuries as well as fatalities, tlie consequence calculation can be repeated using lower intensities of exposure leading to injury rather titan dcatli. In addition, if the adverse healtli effect (e.g. associated with a chemical release) is delayed, the cause may not be obvious. Tliis applies to both chronic and acute emissions and exposures. 

---